Yuanxin Xi
- Geriatrics and Gerontology top 0.5%
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 14
- RNA modifications and cancer 13
- Genomics and Chromatin Dynamics 11
- RNA Research and Splicing 4
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 3
- Cancer-related gene regulation 3
- Hematology top 1%
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 5
- Aging top 5%
- Partner nations
- United StatesChinaFrance
In The Last Decade
Yuanxin Xi
41 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Geriatrics and Gerontology 460
- Molecular Biology 4.2k
- Hematology 640
- Cancer Research 712
- Aging 51
Countries citing papers authored by Yuanxin Xi
This map shows the geographic impact of Yuanxin Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanxin Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanxin Xi more than expected).
Fields of papers citing papers by Yuanxin Xi
This network shows the impact of papers produced by Yuanxin Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanxin Xi. The network helps show where Yuanxin Xi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuanxin Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 50 | |
| 5 | 2019 | 21 | |
| 6 | 2018 | 47 | |
| 7 | 2017 | 103 | |
| 8 | 2017 | 187 | |
| 9 | 2016 | 163 | |
| 10 | 2016 | 169 | |
| 11 | 2016 | 48 | |
| 12 | 2015 | 256 | |
| 13 | 2014 | 289 | |
| 14 | 2014 | 233 | |
| 15 | SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformationbreakdown → | 2012 | 479 |
| 16 | 2011 | 118 | |
| 17 | 2011 | 322 | |
| 18 | Dnmt3a is essential for hematopoietic stem cell differentiationbreakdown → | 2011 | 791 |
| 19 | 2010 | 57 | |
| 20 | BSMAP: whole genome bisulfite sequence MAPping programbreakdown → | 2009 | 840 |
About Yuanxin Xi
Yuanxin Xi is a scholar working on Geriatrics and Gerontology, Molecular Biology and Cancer Research, having authored 43 papers that have together received 5.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), RNA modifications and cancer (13 papers), Genomics and Chromatin Dynamics (11 papers), Cancer Genomics and Diagnostics (5 papers), RNA Research and Splicing (4 papers), Ubiquitin and proteasome pathways (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Geriatrics and Gerontology (460 citations), Molecular Biology (4.2k citations) and Hematology (640 citations). Yuanxin Xi has collaborated with scholars based in United States, China and France. Frequent co-authors include Wei Li, Xiaobing Shi, Kaifu Chen, Deqiang Sun, Sharon Dent, Margaret A. Goodell, Hong Wen, Or Gozani, Mitomu Kioi and Benjamin A. García. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.